Why on earth cant clinical and product get along

Randhir Vieira is a digital health operator turned executive coach for health tech leaders. Over 20+ years, he’s led product and commercial teams at Omada Health (CPO), Headspace (VP Product), and Healthify USA (President), building products used by millions and steering high‑stakes pivots in chronic care, mental health, and metabolic health/GLP‑1.

At Petra Coaching, Randhir blends behavioral science, structured thinking, and hard‑won operator experience. His Maven courses are built the same way: clear frameworks, real case studies, and concrete next steps you can use with your team on Monday morning.

Saranya Loehrer, MD, MPH is a physician-leader who builds the connective tissue across clinical, operational, and executive teams — moving healthcare organizations from admiring problems to delivering results. She spent 11 years at the Institute for Healthcare Improvement, scaling its Leadership Alliance to 50+ U.S. health systems, then served as Teladoc Health’s inaugural Chief Patient Experience Officer and its first Chief Health Equity Officer, building patient-experience and equity functions across the world’s largest virtual care company. She’s lived the clinical-product divide from the inside — and knows it’s structural, not personal. A Rock Health Top 50 in Digital Health honoree, she earned her MD from Loyola and her MPH from Harvard.

Andrew Schutzbank, MD, MPH is a primary-care physician turned product executive who has spent his career building places worth getting care from. He was employee #3 at Iora Health (later acquired by Amazon), where he spent a decade designing a primary-care model — clinical design, training, technology — and took it fully virtual, nationwide, in five weeks when COVID hit. He went on to serve as CPO of Cricket Health (acquired by Fresenius) and taught as Harvard Medical School faculty for ten years. Now founder of Schutzworks, he’s the first call healthtech CEOs, operators, and investors make for the gnarly problems — including the clinical-product divide, which he’s written and spoken about for years.